Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

T he companies behind two of America’s most widely used covid-19 vaccines are at loggerheads. Despite promising publicly not to enforce covid-19-related patents until the pandemic was over ...

One of the companies that developed mRNA vaccines for Covid-19, Moderna, has just sued the companies who make the other mRNA vaccine, Pfizer and BioNTech, claiming a violation of patents. Hey ...

Moderna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc PFE and BioNTech SE BNTX over the Covid-19 vaccine. ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that ...

Summary. Moderna, Inc.'s stock surged 16% yesterday after a German court ruled Pfizer and BioNTech may have violated Moderna's COVID-19 vaccine patent, potentially leading to compensation.

Moderna sues Pfizer, BioNTech over COVID-19 vaccine technology The biotech claims its rivals have infringed on patents issued to Moderna between 2010 and 2016.

Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a continuing dispute with Pfizer and BioNTech over rival COVID-19 vaccines.

Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin ...

Covid-19 vaccine patent legal battle heading to Court of Appeal Moderna, Pfizer and BioNTech are locked in dispute over the rights to vaccine technology patents.